What is the prevalence of Autoimmune Hemolytic Anemia / Cold Agglutinin Disease?

Cold Agglutinin Disease (CAD) is a rare autoimmune hemolytic anemia characterized by the destruction of red blood cells triggered by cold temperatures, with an estimated prevalence of approximately 1 to 2 cases per million people. Because CAD is frequently underdiagnosed or misidentified as other forms of anemia, these figures are considered conservative estimates of the true patient population.

What is the estimated prevalence and incidence of Cold Agglutinin Disease?

Cold Agglutinin Disease is classified as a rare disease. While exact global numbers are difficult to track due to diagnostic challenges, epidemiological studies, such as those cited by Orphanet, suggest a prevalence of 1–2 per 1,000,000 individuals. The incidence—the number of new cases diagnosed annually—is estimated to be approximately 1 per million people per year. Within the DiseaseMaps.org community, 110 individuals have connected to share their experiences with Autoimmune Hemolytic Anemia / Cold Agglutinin Disease, highlighting that while the condition is rare, patients often seek specialized support networks to navigate their diagnosis.

How does age and gender influence the diagnosis of Cold Agglutinin Disease?

Cold Agglutinin Disease predominantly affects older adults, with the median age of onset typically falling between 60 and 70 years old. It is rarely diagnosed in children, where cold agglutinins are more commonly associated with transient secondary conditions following infections rather than the chronic primary form of the disease. In terms of gender distribution, data indicates that females are slightly more frequently affected by Cold Agglutinin Disease than males, though the underlying biological reasons for this slight disparity remain a subject of ongoing clinical research.

What are the challenges in determining accurate prevalence data?

Accurate epidemiological data for Autoimmune Hemolytic Anemia / Cold Agglutinin Disease is difficult to capture for several critical reasons:

• Diagnostic Delay: Symptoms like fatigue, jaundice, and cold-induced acrocyanosis (bluish discoloration of the hands/feet) are often attributed to other, more common conditions.


• Misclassification: Secondary cold agglutinin syndrome, which occurs due to underlying infections or malignancies, is often confused with primary Cold Agglutinin Disease in clinical reporting.


• Geographic Variability: Prevalence data is most robust in North America and Western Europe; there is limited epidemiological data regarding the incidence of Cold Agglutinin Disease in other global regions.


• Under-reporting: Many patients with mild or stable forms of the disease may not seek specialized hematological care, leading to an underestimation of the total burden of illness.

Are there ethnic or geographic predispositions?

There is no strong evidence suggesting that Autoimmune Hemolytic Anemia / Cold Agglutinin Disease is linked to a specific ethnicity. However, because the disease is triggered by cold exposure, environmental factors play a significant role in the clinical presentation and severity of symptoms. Patients living in colder climates may be more likely to experience symptomatic flares, which can lead to a higher rate of medical consultation and formal diagnosis compared to those in warmer regions.

Next steps

• Consult a hematologist with specific expertise in rare autoimmune hemolytic anemias to confirm your diagnosis through a cold agglutinin titer test.


• Keep a symptom log to share with your physician, noting triggers like temperature changes or viral infections.


• Join the DiseaseMaps.org community to connect with other patients and access shared resources for managing the daily impact of this condition.


• Discuss potential clinical trial opportunities with your specialist if standard therapies are not adequately managing your symptoms.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Cold Agglutinin Disease (ORPHA:182138).


• NIH Genetic and Rare Diseases (GARD) Information Center: Cold Agglutinin Disease.


• OMIM (Online Mendelian Inheritance in Man): Cold Agglutinin Disease entry.


• DiseaseMaps.org: Community insights on Autoimmune Hemolytic Anemia and Cold Agglutinin Disease.